ADVERTISEMENT

Piramal Pharma Q1 Results Review - Work In Progress To Revive Business Across Segments: Motilal Oswal

Enhanced outlook for contract development and manufacturing organisation, complex hospital generics egment.

<div class="paragraphs"><p>Piramal Pharma formulation manufacturing unit. (Source: Company website)</p></div>
Piramal Pharma formulation manufacturing unit. (Source: Company website)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit